Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer
Pandey, R., et al. Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer. Translational Oncology 2019 May; 12(5):714-725
Pandey, R., et al. Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer. Translational Oncology 2019 May; 12(5):714-725
Holman, N. S., et al. Hepatocyte-Derived Exosomes Promote Liver Immune Tolerance: Possible Implications for Idiosyncratic Drug-Induced Liver Injury. Toxicological Sciences, 2019; 170(2), 499-508
Takahashi, Y., et al. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head & Neck. 2019 March 11; 1-8. https://doi.org/ 10.1002/hed.25748
Lozano, C., et al. MicroRNAs: Key Regulators to Understand Osteoclast Differentiation? Frontiers in immunology. 2019 Mar 7; 10 (375): doi : 10.3389/fImmu.2019.00375
Hicks, S. W., et al. The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models. Hematologica. 2019 Feb 7; 104(8):1633-1639
Wang, Q., et al. Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Gupta, R., et al. Intercellular Communication between Airway Epithelial Cells is Mediated by Exosome-like Vesicles. American Journal of Respiratory Cell and Molecular Biology. 2019 Feb; 60(2):209-220.
Turner, N. C., et al. Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 2019 Feb 26; 37:1169-1178
Ansell, S. M., et al. Nivolumab for Relapsed/Refractory Diffuse Large B-cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study. Journal of Clinical Oncology. 2019 Jan 8:37(6):481-489
Koshkin, V. S., et al. Transcriptomic and Protein Analysis of Small-cell Bladder Cancer Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target. Clinical Cancer Research. 2019 Jan 1; 25(1) 210-221.
Schaffer, M., et al. Comparison of Immunohistochemistry Assay Results with Gene Expression Profiling Methods for Diffuse Large B-Cell Lymphoma Subtype Identification in Matched Patient Samples. J Mol Biomark Diagn 2018, 9:2 DOI: 10.4172/2155-9929.1000386
Martin-Broto, J., et al. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. Lancet Oncol 2018 Dec. http://dx.doi.org/10.1016/S1470-2045(18)30676-4
Page last updated May 22, 2023